UAE-based asset managers are reallocating capital into Chinese healthcare and high-dividend assets amid volatility and valuation pullbacks in global artificial intelligence equities, Gulf News reported.
Portfolio managers noted that non-technology Chinese equities currently present attractive long-term growth prospects, lower valuation multiples, and higher dividend yields compared to Western peers. Specific holdings in healthcare and biopharma, including BeOne Medicines and Wuxi Biologics, were cited for delivering double-digit gains.
Market analysts emphasized that Gulf investors must carefully monitor cross-currency exposure because the UAE dirham remains pegged to the US dollar. The shift reflects broader diversification by Middle Eastern private capital across emerging Chinese industrial sectors.
Sources
- Gulf News · 2026-11-13
- Gemini News Search — Industry News · 2026-11-15



